LeafNLP Demos
Back to explore

Report #2887010

Received Feb 26, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
57 yrs
State
NC
Recovered
Unknown
Vaccinated
Feb 19, 2026
Onset
Feb 19, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TDAPTDAP (BOOSTRIX)GLAXOSMITHKLINE BIOLOGICALSUNK—SYR

Symptoms (1)

Incorrect route of product administration

Symptom narrative

a patient received a Boostrix vaccine IV, instead of IM Vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of intramuscular formulation administered by other route in a 57-year-old male patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. On 19-FEB-2026, the patient received Boostrix (intravenous). On 19-FEB-2026, an unknown time after receiving Boostrix, the patient experienced intramuscular formulation administered by other route (Verbatim: a patient received a Boostrix vaccine IV, instead of IM Vaccine). The outcome of the intramuscular formulation administered by other route was not applicable. Additional Information: GSK Receipt Date: 20-FEB-2026 The batch number was not provided and a request for this information has been made.